论文部分内容阅读
目的探讨分析骨转移瘤患者采取~(89)SrCl_2联合唑来膦酸治疗的护理干预效果。方法将我院2013年1月至2017年1月的90例骨转移瘤患者随机分为三组,即对照Ⅰ组、对照Ⅱ组和实验组,对照Ⅰ组采取~(89)SrCl_2治疗,对照Ⅱ组采取唑来膦酸治疗,而实验组采取~(89)SrCl_2联合唑来膦酸治疗,并且针对性的给予护理干预,观察并分析三组患者的临床效果。结果经治疗,实验组的临床治疗有效率、治疗前后的焦虑抑郁程度(经SAS评分、SDS评分判定)均优于对照Ⅰ组、对照Ⅱ组,三组的数据具有很大差别,差异具有统计学意义(P<0.05)。结论骨转移瘤患者采取89Sr Cl2联合唑来膦酸治疗具有很好的临床效果,并且适当的护理干预可以改善患者的不良情绪,有利于患者康复。
Objective To investigate the nursing effect of 89 SrCl 2 combined with zoledronic acid in patients with bone metastases. Methods Ninety patients with bone metastases from January 2013 to January 2017 in our hospital were randomly divided into three groups: control group Ⅰ, control group Ⅱ and experimental group. Control group Ⅰ received ~ (89) SrCl_2 treatment, and control group Group Ⅱ was treated with zoledronic acid, while the experimental group was treated with ~ (89) SrCl 2 combined with zoledronic acid and nursing intervention was given accordingly. The clinical effects of the three groups were observed and analyzed. Results After treatment, the effective rate of clinical treatment in experimental group and the level of anxiety and depression before and after treatment (determined by SAS score and SDS score) were superior to those in control group Ⅰ and control group Ⅱ and group Ⅲ, with significant difference Significance (P <0.05). Conclusion 89Sr Cl2 combined with zoledronic acid treatment in patients with bone metastases has a good clinical effect, and appropriate nursing intervention can improve the patient’s bad emotions, is conducive to patient rehabilitation.